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Epidemiological characteristics of sarcoidosis differ according to geographical distribution.
The aim of our study was to disclose epidemiological characteristics in our country.
The data was collected from investigators, who sent information on newly-diagnosed
patients via internet.
In 2 years 198 female and 95 male patients were enrolled to the study (f/m:2.08). Mean age
of patients was 44 13 years (17e90). Mean age of male patients was 38 12 while mean age
of female patients was 48  13 (p< 0.001). 73.4% of patients were nonsmokers (85.4% of
females; 48.4% of males; (p< 0.001)). About 50% of our 293 patients were housewives. Familial
sarcoidosis was found in 3 patients’ first degree relatives. Estimated annual incidence of
sarcoidosis for Turkey was calculated as 4 per 100,000 person.
According to our study, 2/3 of sarcoidosis patients were women; mean age of patients was 45
and the disease began 10 years later in female patients. 80% of patients were nonsmokers;
negative relation between sarcoidosis and smoking was evident especially in women. Familial
sarcoidosis frequency was lower compared to other studies in the literature. There was no
occupational exposure history in our patients. Our incidence rate, is similar with the results
of other European studies.
ª 2008 Elsevier Ltd. All rights reserved.
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Sarcoidosis is a systemic granulomatous disease of
unknown etiology, that affects primarily the lungs. There
are evidences about the etiological role of genetic fac-
tors,1e9 infectious agents,1,10e16 environmental agents 1,17e20
and occupational exposures,1,17,21,22 but the cause(s) of
sarcoidosis still remain unknown. Data about the incidence
of the disease are variable. Annual incidence of
sarcoidosis is reported to be between 0.1 and 81 per
100,000; estimates of prevalence range from 0.1 to 640 per
100,000.
Sarcoidosis is known as a disease of young adults.23,24 In
Scandinavian and Japanese studies, a second peak inci-
dence is reported in women over 50 years old. Most studies
showed higher incidence in women.23e28 However, other
many studies do not confirm this finding.1,17,29,30 Sarcoid-
osis shows different ethnic and geographic distribution. In,
studies from U.S.A., the prevalence of sarcoidosis in blacks
is higher than in whites. It becomes more prevalent in the
areas far from equator. In Europe, it is reported more
frequently in northern countries.
There is an inverse relationship between the risk of
sarcoidosis and the likelihood of being a smoker. Smoking
rate was found between 20 and 55% in sarcoidosis
patients.31e33
Familial cases have been reported since 1920s.2,6,8,34,35
Results of studies for the frequency of familial sarcoidosis
are different; frequency rates of familial cases range from
1 to 19%. It is reported 3e3.5 times more frequently in
AfricaneAmerican patients.8,23
Akkaynak reported the first patient with pulmonary
sarcoidosis in Turkey in 1953.36 There have been case
series after this first report. Gurkan et al. reviewed these
studies.37 Demirkok et al. reported data of 275 patients
from a single institution between 1966 and 2004.38 None
of these studies has the power to represent the real
profile of Turkish patients. So further research is needed
to display the real status of sarcoidosis in our country.Material and methods
This study was organized and conducted by Turkish
Thoracic Society Clinical Problems Study Group.
Turkish Thoracic Society (TTS), is the largest national,
scientific and educational respiratory society in our
country. It has over 2400 members, most of which are chest
physicians. This study was announced via internet to all
members of the TTS. Twenty five investigators from 19
centers of 12 cities in 6 different regions attended to the
study. These investigators are employed in general outpa-
tient clinics of pulmonology departments. These twelve
cities are shown in yellow in Fig. 1.
Study protocol and case record forms were sent to
investigators via internet. Newly diagnosed cases were
recorded to electronic case record forms; these forms were
collected by one of the study investigators.
Cases newly diagnosed as sarcoidosis between 1st June
2004 and 31st May 2006 were enrolled to the study. Existing
cases were ruled out. According to the study protocol,
cases with compatible clinical and radiological findings and
histological non-caseating granulomas were accepted as
sarcoidosis, after exclusion of other causes of granulomas
such as tuberculosis, Crohn’s disease etc. Histological
confirmation was not a necessity for patients with classical
Löfgren’s syndrome.
Statistical analysis was done by SPSS 13 package pro-
gramme. Groups were compared using chi-square and stu-
dent’s t test; p values <0.05 were considered as
statistically significant.
Estimated annual incidence was calculated with the
following method: The total number of patients who
applied annually to the outpatient clinics of all the insti-
tutions in the study-cities was determined (A). The number
of patients who applied to the outpatient clinics of the
study-centers was calculated (B). The ratio of A/B was
established (C ). This ratio was used to calculate the esti-
mated number of sarcoidosis patients (D) with the help of
the reported number of sarcoidosis patients (E ) (D Z EC ).
Figure 1 Cities where the study investigators worked.
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incidence (G) of the disease was estimated (G Z D/F ).Results
In 2 years 198 female and 95 male patients were enrolled to
the study (F/M:2.08). Mean age was 44 13 (min:17,
max:90). Mean age of male patients was 38 12 while mean
age of female patients was 48 13 (p< 0.001) (Figs. 2 and
3).
Eight (2.7%) of the patients were 70 years old or elder; 7
(87.5%) of them were females. Twenty three (7.8%) of the
cases were persons over 65 years of age and 19 (83%) of
them were women.
Familial sarcoidosis was found in 3 patients’ first degree
relatives. There was no sarcoidosis history in second degree
relatives of patients.Figure 2 Age distribution of female patients.73.4% of patients were nonsmokers, 20.8% current
smokers (11 7 pack.years); 5.8% ex-smokers (average
quitting time was 7 7 years ago). 85.4% of females but
48.4% of males were nonsmokers (p< 0.001). Cumulative
cigarette consumption was 11 9 pack.years for men and
11 10 pack.years for women (p> 0.05). Occupations of
patients are shown in Table 1.
The total number of annual applications to outpatient
clinics of centers participated in the study was 189,000. 293
cases were reported from these centers in 2 years. Therefore,
annually 146.5 of 189,000 applications per year were patients
with sarcoidosis. The sum ofannual application toall stateand
university hospitals of cities attended to the study was
1,400,000. Estimated number of patients with sarcoidosis was
1084. Total population of cities attended to the study was
27,000,000. Estimated annual incidence of sarcoidosis for
Turkey was calculated as 4 per 100,000 person.Figure 3 Age distribution of male patients.
Table 1 Occupations of patients.
Occupation n %
Housewife 147 50.2
Office worker,
teacher, student
47 16.0
Health care
worker
(physician, nurse, etc.)
11 3.8
Agricultural worker 9 3.1
Textile worker 8 2.7
Tobacco worker 3 1.0
Electric technician 3 1.0
Driver 3 1.0
Chemistry sector worker 2 0.7
Worker producing glass 2 0.7
Building contractor 2 0.7
Barber 2 0.7
Unoccupied 2 0.7
Firefighter 1 0.3
Miner 1 0.3
Cook 1 0.3
Ceramic worker 1 0.3
Shoemaker 1 0.3
Worker 16 5.5
Other 31 10.6
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To our knowledge, this is the first incidence study about
sarcoidosis in Turkey; the incidence was found 4 per
100,000. Epidemiological studies from other countries
showed different incidence rates. This may be explained by
geographic and ethnic variations. In addition, diagnostic
difficulties, and different methods of the studies may cause
different incidence results. Mainly four different methods
are used for calculating incidence rates; 1) mass radiolog-
ical screening programs, 2) evaluation of countries’ data-
base, 3) questionnaire studies and 4) autopsy studies. Every
method has its own deficiencies. Chest X-ray screening
programs were done on selected populations. Second
method includes cases with definite diagnosis. However, it
is thought that the real incidence rate should be higher
than that of calculated as cases with definite diagnosis,
because 31e68% of patients diagnosed with chest X-ray
screening were asymptomatic.25,27,39e41 The case number
of the autopsy studies are 10 times greater than the
numbers of other methods.
In the United Kingdom, incidence rate was found 8.2 per
100,000 in a radiological screening trial of persons vacci-
nated with BCG aged 15e25 in 1965.27 In 1973, incidence
rate for sarcoidosis in the U.S. navy was found 5.8 per
100,000 for white men and 60.1 per 100,000 for black
men.42 In another study the same method was applied
between 1975 and 2001 in the U.S. navy, incidence rate was
3.5 per 100,000 for Whites, and 24.9 per 100,000 for
Blacks.43 In the U.S.A., between 1967 and 1987, incidence
rate was 4.8 per 100,000 according to the national data-
base.44 Incidence rate was found 7.2 per 100,000 using the
national database in Denmark.45 In Finland incidence wasfound 11.4 per 100,000, with mass chest X-ray screening.46
In questionnaire studies including items for specific diag-
nostic criteria, incidence rate was 0.17 per 100,000 in
Belgium and 0.03 per 100,000 in Korea.47,48 In the U.K. the
review of patients’ database between 1991 and 2003
revealed the incidence as 5 per 100,000.49
Our result is quite similar with the results of the last
British incidence study.
Mean age of overall patients is 43 years. The mean age of
females is 10 years more than mean age of males.
Sarcoidosis has a tendency to be diagnosed about age 50 in
females according to our results. In ATS/ERS/WASOG 1999
Statement on Sarcoidosis it was reported that, the disease
showed a predilection under the age 40, peaking in those
aged between 20 and 29; but in Scandinavian countries in
Japan there was a second peak of incidence in women over
age 50.24 In the ACCESS study the peak age group was
35e45, and the male patients were younger than the
female patients.50 In the recent U.K. study most of the
patients were between 35 and 55 years of age.49 Byg et al.
found the mean age in males and females as 38 and 45
respectively. These results are similar to ours.45
2.7% of our patients were aged 70 years or elder. Except
one, all of these patients were female. Standyk et al. found
that 7.8% of patients were individuals over 65 years of
age.51 In our study this ratio was also 7.8%, too. 83% of
these patients were females. Chevalet et al. showed that
70% of patients over age 70 were women.52 These findings
suggest that sarcoidosis is diagnosed in older ages in
females than those in males.
Hillerdal et al. and Byg et al. showed that the disease
has two peak incidence points in 30 and 50 years of age25,45;
which we could not confirm.
We diagnosed the disease two times more often in
women. Most studies in the literature reported increased
risk in women in comparison to men. In the ACCESS study
female/male ratio was 1.77, but in the British study this
ratio was 1.11.49,50 Investigators suggested that these
different results were related to geographical variations.
Approximately 75% of our patients were nonsmokers.
The smoking history shows some difference in female and
male patients. 15% of female patients but 50% of male
patients were smokers. In normal population 65% of males
and 25% of females smoke in Turkey. Smokers were less
frequent in both female and male patients with sarcoidosis
than those in normal population according to our results.
However negative correlation between sarcoidosis and
smoking was striking especially in women. Smoking
patients’ ratio was lower in other studies of the liter-
ature.18,31e33 Negative correlation between sarcoidosis and
smoking was also supported in the ACCESS study.53
Frequency of familial sarcoidosis was found 1% in our
study. McGrath et al. found this ratio as 5.91% in patients in
the U.K.54 In the study published in 2001 by ACCESS
research group, familial sarcoidosis was found in 3% of
patients.35 There are very different results about frequency
of familial sarcoidosis in the literature. In our study familial
sarcoidosis is less frequent than those in other studies from
different countries.
About 50% of our 293 patients were housewives. 16% of
patients were office worker, teacher or students. The
majority of the patients had not any occupational
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sarcoidosis in firefighters,55,56 health care workers,29,33,57
soldiers,58,59 wood workers60,61; but in the ACCESS study,
a clear relation between sarcoidosis and occupation could
not be disclosed.53 Our finding, that 50% of patients were
housewives, is compatible with this information.
Our incidence rate is in parallel with the results of other
European studies. As nearly half of the patients are
asymptomatic, the real number of cases and the incidence
rate probably should be higher.42 In addition not all the
institutions in the country attended to the study, so our
results may not show the exact number of patients. As
there is no standardized data recording system for all
diseases in our country at present; we do not have a more
reliable method to calculate the incidence of sarcoidosis.
Many centers from all geographical regions of Turkey
attended to our study. Approximately 1/7 of the population
of cities included in the study were sampled. Therefore this
study most probably is able to represent the current status
of sarcoidosis in Turkey.
According to our study, 2/3 of sarcoidosis patients were
women; mean age of patients was 45 and the disease began
10 years later in female patients. 80% of patients were
nonsmokers; negative relation between sarcoidosis and
smoking was evident especially in women. Familial
sarcoidosis frequency was lower than other studies in the
literature. There was no occupational exposure history in
our patients.
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